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Abstract
Background: In HIV-infected macrophages, newly formed progeny virus particles accumulate in intracellular plasma
membrane-connected compartments (IPMCs). Although the virus is usually seen in these compartments, it is
unclear whether HIV assembly is specifically targeted to IPMCs or whether some viruses may also form at the cell
surface but are not detected, as particles budding from the latter site will be released into the medium.
Results: To investigate the fidelity of HIV-1 targeting to IPMCs compared to the cell surface directly, we generated
mutants defective in recruitment of the Endosomal Sorting Complexes Required for Transport (ESCRT) proteins
required for virus scission. For mutants unable to bind the ESCRT-I component Tsg101, HIV release was inhibited
and light and electron microscopy revealed that budding was arrested. When expressed in human
monocyte-derived macrophages (MDM), these mutants formed budding-arrested, immature particles at their
assembly sites, allowing us to capture virtually all of the virus budding events. A detailed morphological analysis of
the distribution of the arrested viruses by immunofluorescence staining and confocal microscopy, and by electron
microscopy, demonstrated that HIV assembly in MDMs is targeted primarily to IPMCs, with fewer than 5 % of
budding events seen at the cell surface. Morphometric analysis of the relative membrane areas at the cell surface
and IPMCs confirmed a large enrichment of virus assembly events in IPMCs.
Serial block-face scanning electron microscopy of macrophages infected with a budding-defective HIV mutant
revealed high-resolution 3D views of the complex organisation of IPMCs, with in excess of 15,000 associated HIV
budding sites, and multiple connections between IPMCs and the cell surface.
Conclusions: Using detailed quantitative analysis, we demonstrate that HIV assembly in MDMs is specifically
targeted to IPMCs. Furthermore, 3D analysis shows, for the first time, the detailed ultrastructure of an IPMC within a
large cell volume, at a resolution that allowed identification of individual virus assembly events, and potential
portals through which virus may be released during cell-cell transfer. These studies provide new insights to the
organisation of the HIV assembly compartments in macrophages, and show how HIV particles accumulating in
these protected sites may function as a virus reservoir.
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Background
HIV primarily infects activated T cells, in particular ef-
fector memory T cells, and macrophages expressing
CD4 and the co-receptor CCR5 (Reviewed in [1–3]).
Subsequently, following replication, progeny viruses are
produced through the assembly of the main viral com-
ponents at the plasma membrane of infected cells. A key
difference in HIV assembly in these different host cells is
that, in mature macrophages, newly formed virions
accumulate in characteristic highly interconnected intra-
cellular compartments [4–9]. Many of these compart-
ments have been shown to be connected to the plasma
membrane, so that they are now known as intracellular
plasma membrane-connected compartments (IPMCs).
The compartments contain various markers typical of
the plasma membrane, including proteins such as CD44,
the tetraspanins CD9, CD81 or CD53 [4, 10], as well as
β2 integrins (CD18 with CD11b and/or CD11c) and as-
sociated proteins that can form focal adhesion-like struc-
tures [7, 9] or the scavenger receptor CD36 [11]. In
addition, the plasma membrane and IPMC membranes
both contain cholesterol and phosphatidylinositol-4,5-
bisphosphate [PtdIns(4,5)P2] [3, 9]. Similar compart-
ments are present in differentiated/mature uninfected
monocyte-derived macrophages (MDMs), but are ex-
panded upon HIV infection [4, 7, 10, 11]. In addition,
similar compartments have been seen in lymph node
macrophages in vivo [12] or in isolated placental Hoff-
bauer cells [13], and appear also to be present in gut-
associated lymphoid tissue of HIV-infected humanized
mice [14]. Notably, when HIV-infected MDMs interact
with autologous CD4+ T cells, viruses contained within
IPMCs can be released through virological synapses
leading to efficient infection of the T cells [15–18]. Mac-
rophages become prominent target cells of HIV in ad-
vanced disease and AIDS, when CD4+ T cells are
depleted [19]. In particular, HIV-infected monocytes in-
vading the brain differentiate to macrophages that mediate
neuroinflammation and contribute to pathogenesis and
HIV-associated neurocognitive disorders (reviewed in
[20–22]). Furthermore, these cells may represent a viral
reservoir at this immunologically privileged site [23, 24].
HIV assembly is targeted to the plasma membrane via
PtdIns(4,5)P2, which binds the Matrix (MA) domain of
the main virally encoded structural protein p55Gag [25–
27]. As PtdIns(4,5)P2 has been shown to be present in
IPMCs, as well as at the cell surface proper, both loca-
tions should be able to support virion formation. How-
ever, the fate of viruses budding at the cell surface or
within IPMCs would differ, in that viruses assembling at
the cell surface would be released into the extracellular
fluids and may be able to infect other distant cells via
cell-free infection. By contrast, viruses that accumulate
in IPMCs could be stored in an infectious form for
extended periods of time [28] and may be a source of
virus for direct cell-to-cell transmission to non-infected
target cells. Despite these different viral fates, to date,
there has not been a rigorous analysis to address
whether, in infected macrophages, HIV assembles pri-
marily within IPMCs or whether a proportion assembles
at the cell surface and is released directly into the
medium.
Herein, we have addressed this question by generating
HIV-1 mutants defective in the recruitment of Endoso-
mal Sorting Complexes Required for Transport (ESCRT)
proteins required for virus scission [29, 30] (reviewed in
[31]). When expressed in MDMs, these mutant viruses
formed immature virus buds that were arrested at their
budding sites, allowing the visualisation of all virus as-
sembly events. Detailed analysis of HIV assembly sites
by confocal imaging and by electron microscopy (EM)
demonstrated that HIV assembly in MDMs is targeted
primarily to the IPMCs. Furthermore, using serial block-
face scanning EM of MDMs infected with a budding-
defective HIV mutant, we constructed a high-resolution
3-dimensional (3D) model of the complex organisation
of the IPMC in relation to the cell surface and mapped
the associated HIV budding sites. These studies indicate
that, in infected mature MDMs, HIV assembly is tar-
geted to IPMCs, provide a deeper understanding of the
organisation of the HIV assembly compartments in
MDMs, and show how infected macrophages accumulat-
ing HIV particles in these protected sites may function
as a virus reservoir.
Results
Generation of budding-arrested HIV-1 proviruses
HIV requires the ESCRT machinery to complete bud-
ding and release free virions [31–34]. Thus, we exploited
the ability to inhibit recruitment of the ESCRT machin-
ery to arrest virus budding and allow analysis of all the
sites where virus assembly is targeted in MDMs. Al-
though ESCRT components, such as Tsg101 (tumour
susceptibility gene 101) and/or ALIX (ALG-2-interacting
protein X), were efficiently depleted by siRNA, we ob-
served little effect on virus release (Additional file 1:
Figure S1), which probably reflects the difficulty of
achieving effective knockdown of the ESCRT proteins in
the cells infected with HIV.
As an alternative approach, we generated full-length
release-defective HIV-1 R3A proviral clones in which
the ESCRT interacting motifs were disrupted. Specific-
ally, the PTAP motif in the p6 domain of Gag, which is
required to recruit Tsg101, was mutated to LIRL ([29],
hereafter referred to as PTAP–), or the first two amino
acids of the consensus sequence for ALIX interaction,
YPLASL, were changed to SR ([30], hereafter referred to
as YP–), or these mutations were combined in a PTAP–
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YP– provirus. Alternatively, the entire p6 domain was
deleted to generate the Δp6 mutant (Additional file 2:
Figure S2). To verify that these mutants were budding
arrested, the proviral constructs were transfected into
HEK 293 T cells and the media and cell lysates analysed
for released virions and viral proteins, respectively, by
SDS-PAGE and western blotting (Fig. 1a). Analysis of
cell lysates revealed that similar amounts of the Gag
polyproteins were expressed for all proviruses, with the
expected molecular weights; the Δp6 Gag migrated at
about 49 kDa, while PTAP– containing mutants showed
the characteristic mobility shift for p55Gag and in-
creased levels of the processing intermediate p41 (repre-
senting a matrix-capsid fragment), as has been described
previously [29, 35]. Analysis of released particles in the
media showed a strong decrease in both p55Gag and the
processed capsid protein p24 in media from cells trans-
fected with the PTAP–, PTAP–YP– and Δp6 proviruses.
The presence of p55Gag in the culture supernatants is
indicative of immature viruses, but may also arise from
sheared immature particles, microvesicles or cell debris.
The nearly complete absence of mature processed p24
in supernatants from the PTAP–, PTAP–YP– and Δp6 vi-
ruses suggests that bone fide budding of progeny virions
is arrested.
Similar cultures of HEK 293 T cells were processed for
morphological analysis either by cryosectioning and
immunolabelling, or embedding in Epon for EM. Ana-
lysis of semi-thin immunolabelled cryosections by fluor-
escence microscopy showed frequent infected cells,
identified by cytoplasmic p24/p55 Gag labelling (Fig. 1b).
Assembling virus particles appeared as brightly stained
puncta at the cell surface (see p24/p55 panels, green).
Notably, for cells transfected with HIV-1 R3A wild type
(WT), some of these puncta could be co-labelled with
an antibody (mAb 4C9) that is specific for the proteo-
lytically cleaved MA protein p17 (red), indicating that
they are mature or maturing virions. While p55-stained
cell surface particles were also seen for cells transfected
with the PTAP– or Δp6 proviruses, consistent with virus
budding, these failed to co-label for p17, indicating that
they had not undergone maturation. A budding arrested
phenotype was directly confirmed by EM (Fig. 1c). Cells
expressing R3A WT contained few virus particles, al-
though some mature virions could be found, for example
trapped between cells. For cells transfected with the mu-
tant proviruses we only observed arrested buds with
various degrees of curvature and lined with the thick
Gag layer characteristic of immature HIV particles.
This demonstrated that proviral clones unable to re-
cruit Tsg101 (the PTAP– and Δp6 mutants) were in-
deed arrested late during particle assembly, with
incomplete, immature particles retained at their cell
surface budding sites.
Expression of budding-arrested HIV proviruses in primary
MDMs
To determine where these HIV mutants assemble in
macrophages, monocytes isolated from donor buffy
coats and differentiated to MDMs for 14 days were elec-
troporated with the proviral clones and returned to cul-
ture for 24 h, when the cell lysates and released virions
in the media were collected and analysed (Fig. 2a). Al-
though the transfection efficiencies were low for these
primary cells (<1 %), we did detect expression of the
Gag polyproteins, with the lowest expression levels for
the YP– mutant. Analysis of the supernatants revealed
robust release of HIV-1 R3A WT; by contrast, and as
observed for transfected HEK 293 T cells, release of the
PTAP– or Δp6 proviruses was significantly reduced, in-
dicating that completion of HIV budding is also ESCRT-
dependent in macrophages.
Cultures of transfected MDMs were also fixed and
immunolabelled with antibodies against the hyaluronic
acid receptor CD44, a marker of the plasma membrane
and IPMCs, and against Gag p24/p55, to identify in-
fected cells and determine the location of the virus parti-
cles or buds, and analysed by confocal microscopy
(Fig. 2b). For MDMs transfected with HIV-1 R3A WT,
or the PTAP– or Δp6 mutants, infected cells were seen
in the cultures, and in all cases puncta of Gag p24/p55
staining were located primarily within CD44+ IPMC
structures (Fig. 2b). Only a few cells expressed the Δp6
mutant, precluding any quantitative analysis. For the
WT and PTAP– transfections, coverslips were systemat-
ically searched and any Gag-expressing cells scored for
whether Gag puncta were seen exclusively within CD44+
IPMCs, at the cell surface, or at both locations. This
revealed that, in most MDMs, virus staining was only
detected in the IPMCs (60 % and 72 % of cells, respect-
ively, Fig. 2c), suggesting that virus assembly is targeted
to this site. Notably, those cells in which virus staining
was seen exclusively at the cell surface lacked detectable
intracellular CD44+ IPMCs.
To overcome the very low transfection efficiencies in
primary MDMs and analyse HIV budding sites at higher
resolution and more quantitatively, we prepared infec-
tious stocks of the budding-arrested proviruses. HEK
293 T cells were co-transfected with the PTAP– and
PTAP–YP– mutants together with pCMVGag, which ex-
presses WT p55Gag, at a ratio of 12:1 (Additional file 2:
Figure S2). This produced infectious virus stocks that
could be used for single-cycle infections. MDMs were
differentiated from monocytes for 7 days and then in-
fected with HIV R3A WT or the rescued ESCRT mutant
virus stocks and cultured for a further 7 days before fix-
ation and analysis by immunofluorescence staining and
confocal microscopy (Fig. 3 and Additional file 3: Figure
S3 and Additional file 4: Figure S4). In MDM cultures
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infected with HIV-1 R3A WT, many cells had strong ac-
cumulations of viruses in IPMCs marked by CD44. Not-
ably, these virus accumulations could be stained with
antibodies against the capsid protein that react with both
p55Gag and p24, as well as with the 4C9 antibody spe-
cific for the mature p17 matrix protein, indicating that
these are mainly mature virus particles that have com-
pleted budding. For the mutants, p24/p55 staining was
Fig. 1 Characterisation of HIV-1 R3A p6 domain mutants in HEK 293 T cells. HEK 293 T cells were transfected with the indicated HIV-1 pNL4.3-R3A
constructs (see Additional file 2: Figure S2A), and cultured for 24 h before analysis. a Western blot of cell lysates and released virions purified from the
media. Blots were probed with antibodies against viral p24/55 or adaptin-γ as a loading control. The positions of p55Gag, Gag protein lacking the p6
domain (p55Δp6), the p41 cleavage product and mature p24 are indicated. Band signal intensities were quantified using ImageJ to determine the virus
release efficiencies shown below the blot (data from two independent experiments ± standard deviation). b Immunofluorescence staining of semi-thin
cryo-sections (0.5 μm) with antibodies against p24/55 (38:96 K and EF7, green) and p17 (4C9, red). Bright puncta of p24/p55 (e.g. at the green
arrowheads) indicate assembling viruses. For the R3A WT, some mature cell surface puncta were labelled for p17 (red arrowheads) suggesting they are
mature virions, but for the PTAP– and Δp6 mutants, the cell surface contained only p24/p55-labelled puncta (green) devoid of p17 staining, indicative
of immature virus buds. Scale bars, 10 μm. c Ultrastructure of HEK 293 T cells expressing the indicated HIV-1 R3A constructs. Transfected cells were
embedded in Epon and processed for electron microscopy. Cells expressing the HIV-1 R3A WT contained rare mature virus particles such as the group
of particles trapped between adjacent cells shown here. Arrows mark electron-dense cores visible in some of the particles. In contrast, only immature
budding-arrested virus particles were seen on cells expressing the PTAP–, PTAP–YP– and Δp6 mutant proviruses. Scale bars, 200 nm
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also seen within IPMC structures, but there was little re-
activity with the p17 antibody, consistent with a
budding-arrested phenotype (Fig. 3b, c and Additional
file 3: Figure S3). On a few cells p24/p55 staining was
seen in IPMCs as well as at the cell surface (Fig. 3d,
Additional file 4: Figure S4A), while some infected
MDMs lacked CD44-labelled IPMCs, and displayed p24/
p55-stained virus puncta only at the cell surface (Fig. 3e
Fig. 2 Transfection of monocyte-derived macrophages (MDMs) with HIV-1 R3A WT, PTAP– or Δp6 mutants by electroporation. Fourteen-day-old MDMs
were electroporated with the indicated provirus constructs and incubated for 24 h before analysis. a Released virions were collected and virus pellets and
cells were lysed and analysed by western blotting as detailed in Fig. 1b, and signal intensities were quantified using ImageJ to determine the virus release
efficiencies shown below the blot (data from three independent experiments ± standard deviation). b Cells were fixed and stained with antibodies to
p24/55 (38:96 K and EF7, green) and CD44 (magenta). Representative single confocal sections from z-stack series are shown. Scale bars, 10 μm. c
Distributions of virus staining on the immunolabelled MDMs (samples from three different blood donors). Coverslips were scanned systematically and
virus-expressing cells scored into three categories of cells where virus was seen in the intracellular plasma membrane-connected compartments (IPMCs)
only (blue), in IPMCs as well as the cell surface (grey), or only at the cell surface (white; these latter MDMs lacked CD44+ IPMCs)
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and Additional file 3: Figure S3). To determine the dis-
tribution of the viruses and/or buds more quantitatively,
we scored cells from five blood donors according to the
distribution of the stained virus puncta (Fig. 3f ). As for
the transfected MDMs (Fig. 2), the majority of cells con-
tained virus staining only in the IPMCs. Again,
approximately 20–25 % of cells lacked IPMCs, but in
cells where the compartments were present, virus as-
sembly appeared to be targeted to these sites. Overall, in
MDMs expressing HIV-1 R3A either after transfection
(Fig. 2) or after infection with rescued virus stocks
(Fig. 3), 66 % of cells infected with WT, or 77 % of cells
Fig. 3 Distribution of HIV-1 R3A WT or the PTAP–YP– and PTAP– mutants in infected monocyte-derived macrophages (MDMs). Seven-day-old MDMs
were infected with HIV-1 R3A WT or the rescued release-defective viruses HIV-1 R3A PTAP−YP− or PTAP− (see Additional file 2: Figure S2). Cultures were
incubated for a further 7 days, fixed and immunolabelled with antibodies against p24/55 (Kal-1, green), p17 (4C9, red) and CD44 (magenta), and
examined by confocal microscopy. a–e Selected single optical sections from z-stacks of MDMs infected with WT (a) or the PTAP–YP– mutant (b–e, two
different sections are shown for the cell in d). Arrows point out the intracellular plasma membrane-connected compartments (IPMCs). The boxed area
in (d) is enlarged in the insets, revealing a single immature virus bud at the cell surface. Scale bars, 20 μm. f Quantitative analysis of virus distributions
on MDMs from five different blood donors. Coverslips were scanned systematically and virus-expressing cells scored into three categories of cells
where virus was seen in the IPMCs only (blue), in IPMCs as well as the cell surface (grey), or only at the cell surface (white; these latter MDMs lacked
CD44+ IPMCs). g For selected cells with Gag p24/55 labelling both at the IPMC and the cell surface, the proportion of p24/p55 fluorescence in the
IPMC was estimated and plotted. p24/p55Gag fluorescence was primarily in the IPMC for the WT (>80 %), and for cells from two donors infected with
PTAP−YP− mutant virus (>90 %). See also Additional file 3: Figure S3 and Additional file 4: Figure S4
Nkwe et al. BMC Biology  (2016) 14:50 Page 6 of 18
with PTAP– or PTAP–YP– mutant viruses, only had
virus staining in IPMCs. These observations suggest that
HIV assembly is targeted specifically to the IPMCs.
For more quantitative analysis of the levels of viruses
in infected cells, we recorded complete confocal z-stacks
from random fields of infected MDMs, and measured
the total fluorescence intensity for p24/55 and p17 stain-
ing of the infected cells (Additional file 4: Figure S4B
and C, respectively). This confirmed strong labelling for
viral p24/p55, though with somewhat stronger labelling
of cells infected with WT virus compared to the PTAP–
YP– mutant (Additional file 4: Figure S4B). By contrast,
strong labelling with the anti-p17 antibody specific for
the cleaved MA was only seen for MDMs infected with
R3A WT, while cells infected with the PTAP–YP– mu-
tant had rare p17-stained puncta, consistent with occa-
sional events where HIV protease may have been
activated prematurely in the bud [36] (overall ratio of
fluorescence intensity of WT to PTAP–YP– mutant ap-
proximately equal to 7×) and many cells infected with
the PTAP–YP– lacked p17 fluorescence (Additional file
4: Figure S4C). This supports the notion that the PTAP–
YP– virus buds are arrested prior to bud scission, and
consequently also to proteolytic maturation. In these
MDMs the immunostained virus puncta were also lo-
cated primarily in IPMCs. For cells where the 3D con-
focal stacks indicated virus staining both in the IPMC
and at the cell surface (and where IPMCs were clearly
separated from the cell surface), the IPMC staining was
segmented and measured relative to the total p24/p55
fluorescence of the cell. This demonstrated that, on a
per cell basis, more than 90 % of the virus labelling was
in IPMCs (Fig. 3g). Thus, for MDMs that express IPMC
domains, the IPMC is the main site where HIV assem-
bles. The higher levels of cell surface viruses on cells in-
fected with HIV-1 WT is consistent with higher levels of
infection and larger numbers of viruses, and suggests
that some HIV particles may be re-directed to the PM
as the IPMC becomes crowded.
These studies strongly support the view that HIV is
predominantly assembled at IPMCs in primary human
macrophages.
Ultra-structural analysis of HIV assembly sites in infected
primary MDMs
To analyse the exact locations where the viruses assem-
ble, MDM cultures infected with HIV-1 R3A WT or the
rescued PTAP– or PTAP–YP– proviruses were fixed and
processed for cryosectioning and immuno-EM, and ul-
trathin sections were stained with antibodies against the
HIV Gag protein and protein A-gold. Examination of
MDMs infected with R3A WT showed frequent infected
cells with extensive IPMCs packed with gold-labelled vi-
ruses (Fig. 4a, b). At high magnification, the majority of
the particles had electron-dense cores, and sometimes
the triangular or circular profiles of the truncated cone-
shaped cores of mature virus particles could be distin-
guished. Occasional particles also showed the character-
istic ring of intact p55Gag indicative of immature virus
particles (Fig. 4b and inset).
The number of infected cells was lower for cultures in-
fected with the PTAP– or PTAP–YP– preparations, prob-
ably because budding arrested mutants, in contrast to
HIV-1 WT viruses, are unable to establish spreading in-
fections. For the mutants we therefore used correlative
on-grid immunofluorescence staining to locate infected
cell profiles. Ultrathin cryosections were placed on
finder grids and labelled with anti-p24/p55 antibodies, a
fluorescent rabbit anti-mouse bridging antibody and
protein A-gold. Fluorescence imaging was used to iden-
tify infected MDMs and re-find the cells in the EM
(Fig. 4c, d). At higher power, the fluorescent staining
correlated with IPMC structures filled with gold-labelled
immature virus profiles (Fig. 4e–g). Notably, most cell
profiles lacked arrested buds directly at the cell surface.
Similar analysis of MDMs infected with a rescued
PTAP–YP– virus stock is shown in Fig. 5. Again, the
IPMCs usually consisted of complex membrane mesh-
works with interconnected pockets and associated im-
mature virus buds. To better understand the structures
of the compartments, cell profiles with labelled virus
buds were photographed at high magnification and the
cell surface and membranes lining the virus-containing
IPMCs were traced. This revealed the very complex na-
ture of the compartments (Fig. 5d, g). In many of the
cell profiles, IPMCs were found deep within the cell,
while other cell profiles showed IPMC structures close
to or joining with the cell surface. Since EM allowed us
to identify individual budding figures, we counted virus
profiles within IPMCs or directly at the cell surface, and
the 2D lengths of membrane in the sections were calcu-
lated from the tracings. Overall, we analysed cell profiles
from four blood donors infected with either PTAP– or
PTAP–YP– viruses (Table 1 and Additional file 5: Table
S1). More than 95 % of all the HIV budding profiles
were located within IPMC structures. For the density of
virus buds per unit membrane, budding profiles in
IPMCs were found to be enriched at least 40×, and over-
all by 57×, compared to the cell surface, though this var-
ied between donors and the different cells examined
(Table 1 and Additional file 5: Table S1). These results
strengthen the argument that HIV assembly is targeted
with high fidelity to the IPMCs.
Imaging HIV assembly sites by serial block-face EM and
3D reconstruction
Our studies by correlative light and EM of cryosections
captured various random views through infected cells
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Fig. 4 (See legend on next page.)
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and revealed a variety of arrangements of the IPMCs
relative to the cell surface. To determine how these
structural views might relate to each other in 3D we
used serial block-face EM [37]. MDMs infected with the
R3A PTAP–YP– mutant were labelled with CellMask or-
ange plasma membrane stain, which can access IPMCs
through their surface connections [9], and cells with
prominent IPMCs were identified. Herein, we show one
cell with a prominent IPMC (Fig. 6a, b). Initial en face
ultrathin sections from the basal surface of the cell, adja-
cent to the coverslip, confirmed that it was infected,
with accumulations of viruses in the IPMC. This cell
was therefore imaged by serial block-face scanning EM,
where we collected a data set of 300 sections, represent-
ing a total volume of 32.8 × 32.8 × 15 μm with voxel size
4 × 4 × 50 nm (Additional file 6: Figure S5 and
Additional file 7: Movie S1). Selected sections and 3D
reconstructions from this cell are shown in Fig. 6 and
Additional file 8: Figure S6 and Additional file 9: Movie
S2. The first section of the set (section 0) shows the lo-
cation of the IPMC adjacent to the nucleus, with virus
buds visible within the compartment (Fig. 6c–e, see also
Additional file 8: Figure S6). Manual segmentation of
the IPMC and cell surface membranes allowed us to
generate a 3D model of the cell, while virus buds were
identified and manually placed in the model using the
TrakEM2 module of ImageJ. Various views of the IPMC
are shown in Fig. 6f–h. As already apparent from the
CellMask stained image, this IPMC consisted of two
connected portions (marked I and II in Fig. 6). The
smaller portion (marked I, Fig. 6f, g) was relatively com-
pact (diameter approximately 4 μm) and contained large
numbers of HIV buds. A narrow channel connected this
part of the IPMC to the cell surface (Fig. 6f, g). The adja-
cent larger portion of the IPMC (marked II) consisted of
a complex network of convoluted membranes with nar-
row connections as well as wider channels and branches,
becoming increasingly complex towards the top and
eventually opening to the cell surface at multiple sites.
The cell surface itself appeared rather convoluted, with
numerous membrane processes, protrusions and bleb-
like structures.
We also analysed the locations of the budding HIV
particles in relation to the IPMC and cell surface mem-
branes. Immature virus particles were found throughout
the IPMC, including the channels, branching membrane
mesh-works and connections towards the cell surface,
indicating that all parts of the IPMC have the potential
to support HIV budding. Although most of the cell sur-
face was devoid of viral budding profiles, some buds
were noted at the cell surface in higher sections near the
top of the cell (Fig. 6i and Additional files 6, 7, 8 and 9).
Altogether, we identified 15,264 virus particles in the
IPMC and 2085 particles at the cell surface and among
the membrane protrusions and blebs, with surface virus
buds representing about 12 % of the total viruses in the
images from this cell. Notably, these virus buds were not
distributed evenly over the cell surface, but appeared
concentrated around sites where the IPMC joins the cell
surface (Fig. 6k–m and Additional file 8: Figure S6 and
Additional file 9: Movie S2). The arrangement of virus
buds seen in this cell corresponds to the various differ-
ent arrangements of buds in IPMCs or at the cell surface
seen on the cryosections (see above), where we observed
cell profiles with IPMCs deep in the juxta-nuclear area,
or close to and connecting with the cell surface.
Notably, since this analysis was done on MDMs infected
with mutant HIV unable to complete budding, virtually all
assembly events should have been captured for analysis.
The predominant localization of HIV buds in IPMCs, seen
by immunofluorescence and confocal microscopy, as well
as different EM methods, suggests that HIV assembly is
specifically targeted to the IPMCs in MDMs.
Discussion
In this study, we have addressed the question of whether
HIV assembly in MDMs preferentially takes place in the
IPMCs, or whether the virus also assembles directly at
the cell surface and is immediately released into the
medium. Using HIV mutants unable to complete the
ESCRT-dependent scission reaction, we arrested viruses
at their budding sites, which allowed us to capture es-
sentially all HIV assembly events. Analysis of infected
cells by confocal microscopy, or of ultrathin cryosections
(See figure on previous page.)
Fig. 4 Electron microscopy (EM) immunolabelling of cryosections from monocyte-derived macrophages (MDMs) infected with HIV-1 R3A WT or the
PTAP− mutant. Seven-day-old MDMs were infected with HIV-1 R3A WT or the rescued release-defective HIV-1 R3A PTAP−. After a further 7 days, cells
were fixed and processed for cryosection immunolabelling. Ultrathin cryosections were immunolabelled with antibodies against p24/55, a fluorescent
rabbit-anti-mouse bridging antibody and protein A-gold, or double-labelled for Env as indicated. a, b MDMs infected with HIV-1 R3A WT. Many cells
contained intracellular plasma membrane-connected compartments (IPMCs) packed with electron-dense mature virus profiles. The approximate
location of the cell surface is indicated by the dashed blue line. Arrows indicate occasional immature viruses (detail shown in the inset). c–g MDMs
infected with the HIV-1 R3A PTAP− mutant. c On-grid immunofluorescence staining with the fluorescent bridging antibody (green) shows the location
of a cell with IPMC near the corner of grid bars (white arrow). d EM image of the same cell. Note the characteristic pattern of the four nuclei (marked
with *) for orientation, indicating the location of the IPMC (white arrow). e A higher power montage image of the boxed area in (d) showing the
intracellular membranes with associated immature virus buds (see insets). f A similar view of an IPMC from another experiment. The marked area is
shown enlarged in (g). Scale bars: a, 2 μm; b, 500 nm; c, d, 10 μm; e, 1 μm; f, 2 μm; g, 500 nm; and all insets, 100 nm
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by transmission EM, showed fewer than 5 % of HIV
buds at the cell surface and revealed a large enrichment
of immature viruses in the IPMCs. Similarly, reconstruc-
tion of an infected macrophage by serial block-face
scanning EM revealed the intricate structure of the
virus-filled IPMC, with cell surface virus buds located
predominantly near connections between the IPMC and
the cell surface.
Fig. 5 Immuno-electron microscopy (EM) of monocyte-derived macrophages (MDMs) infected with HIV-1 R3A PTAP−YP−. Seven-day-old MDMs
were infected with HIV-1 R3A PTAP−YP− for a further 7 days, fixed and processed for cryosection immunolabelling with antibodies against p24/55,
and protein A-gold as in Fig. 4. A rabbit-anti-mouse Alexa-488 bridging antibody was used to locate infected cells by on-grid correlative light and
EM. a A representative cell from Donor 429 located by on-grid immunolabelling. The marked area from the intracellular plasma membrane-
connected compartment (IPMC) is shown at higher magnification in (b). c View of the area marked in (b) to show the immature phenotype of
the budding-arrested virus particles. d Segmentation of the cell surface (grey) and IPMC membranes (black). Virus buds were counted and the
lengths of membrane in the section calculated from the segmentations. e–g A partial cell profile from another infected cell, Donor 432. e Low
power overview of the cell profile as seen emerging from under the grid bar. f Higher magnification detail of the marked area showing the IPMC.
The arrow indicates an opening from the IPMC to the cell surface and arrowheads in (e) and (f) mark the five immature virus particles at the cell
surface. g Segmentation of this cell as in (d). The length of the grid bar indicated by the dashed line was not included in the analysis. Scale bars:
a, d and g, 5 μm; b and e, 2 μm; c, 200 nm; and f, 1 μm
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The ability to arrest virus budding by mutating the
ESCRT-interacting motifs in the p6 portion of Gag con-
firms that, as in other systems, the ESCRT machinery is
also essential for HIV budding in MDMs [8, 11, 29, 38].
For the PTAP– and PTAP–YP– mutants, we only de-
tected immature budding profiles. This was clear from
staining with an antibody to p17 that only detects the
cleaved MA protein. The HIV protease is only active as
a dimer, and Gag proteolysis is generally believed to
occur concomitant with or shortly after bud scission
when the GagPol precursors are able to interact and ini-
tiate proteolysis [39]. Although we generally saw little
MA staining in cells expressing the budding-arrested
HIV mutants, we did notice occasional cleavage in
arrested buds, particularly in cells expressing very high
levels of Gag. Overall, in MDMs infected with the
PTAP–YP– mutant, levels of the processed MA were re-
duced more than 7-fold (Additional file 4: Figure S4C);
furthermore, at the EM level, we never detected particles
with clear virus cores.
To identify in detail the sites of HIV assembly, large
numbers of MDMs isolated from eight different blood
donors were analysed by immunofluorescence confocal
microscopy and more than 1000 cells were scored for
virus distributions (Figs. 2 and 3). Importantly, immuno-
fluorescence staining for Gag p24/55 revealed accumula-
tions of viruses in IPMCs both in MDMs transfected
with HIV proviruses and fixed after 24 h (Fig. 2), as well
as in cells infected with WT or rescued ESCRT mutant
virus preparations and examined 7 days post-infection
(Fig. 3). This indicates that virus targeting to the IPMCs
is not dependent on how long the cells have been in-
fected. Furthermore, ultrathin cryosections of infected
MDMs from four of these donors were studied by EM
(Figs. 4 and 5, and Table 1). HIV buds were seen almost
exclusively in the IPMCs, indicating that, in MDMs
where IPMCs were present, HIV assembly is directed to
these compartments. Although all these studies were on
fixed cells, live cell imaging studies with Gag-GFP also
suggest that Gag assembly is first detected in the IPMCs
[8, 9]. Together, these studies show that the accumula-
tions of intracellular HIV particles in MDMs are due to
direct targeting of virus budding to the IPMCs and not
to extensive internalisation of virus particles.
It is not clear how the virus targets IPMC membranes in
preference to the cell surface. Gag binding to the cytoplas-
mic face of the plasma membrane requires PtdIns(4,5)P2,
but since PtdIns(4,5)P2 is also present at the cell surface
[9], there must be other distinguishing features between
the membranes of IPMCs and the cell surface. It is possible
that there may be variation in the local PtdIns(4,5)P2 con-
centration, or differences in the PtdIns(4,5)P2 fatty acid
chains that may contribute to local heterogeneity in mem-
brane fluidity or lipid phases (see [40]), allowing stronger
Gag binding to IPMCs. Most cellular proteins that have
been identified in the IPMCs are also present at the cell
surface [4, 7, 10, 11], though again there may be differences
in the local abundance of these proteins.
Since it became clear that the virus-containing com-
partments in MDMs are actually connected to the cell
surface [4, 10], there have been studies to delineate the
fine structure of these compartments at the EM level.
For analysis of the 3D structure of the IPMCs, imaging
approaches have included ion-abrasion scanning EM
[41], EM tomography [6] or serial section transmission
EM [42], which all revealed the complex organisation of
the IPMCs with many internal membranes and convo-
luted interconnected membrane mesh-works. Our serial
block-face scanning EM imaging provides a significantly
more comprehensive view of IPMCs. We have been able
to image a much larger volume than was achieved in
previous studies (>50,000 μm3), at a resolution
Table 1 Quantitation of virus buds and membrane lengths for cryosections of MDMs infected with budding-arrested HIV-1 mutants
Mutant No. of cell
profiles analyseda
Cell surface IPMC % of buds
in IPMC
Enrichment of













D415c 7 (5) 26 2620 0.0099 1137 1378 0.8248 97.8 83 ×
PTAP–YP–
D428 9 (5) 4 2041 0.0020 719 931 0.7723 99.4 394 ×
D429 12 (11) 89 5278 0.0169 1149 1814 0.6333 92.8 38 ×
D432 6 (5) 44 2486 0.0177 417 483 0.8633 90.5 49 ×
Overall total 34 (26) 163 12,424 0.0131 3422 4607 0.7428 95.5 57 ×
Monocyte-derived macrophages (MDMs) from four different donors were infected with the HIV-1 R3A mutants PTAP– or PTAP–YP–, and infected MDMs located by
on-grid immunolabelling. Electron microscopy images were recorded and analysed by counting the number of virus buds seen either at the cell surface or within
intracellular plasma membrane-connected compartment (IPMCs). Linear lengths of surface or IPMC membrane within the sections were measured by tracing
(see Methods)
a The number of cell profiles for which viral buds were counted and membrane lengths measured (the number of distinct cells analysed is given in brackets)
b The ratio of the density of buds/μm of membrane in the IPMC compared to the cell surface is shown as fold enrichment
c Donor ID
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Fig. 6 (See legend on next page.)
Nkwe et al. BMC Biology  (2016) 14:50 Page 12 of 18
comparable to EM tomography. Our studies revealed
the major portion of a large IPMC in which we were able
to identify and count individual immature virus buds. The
overall structure of the compartment resembles IPMCs re-
vealed by fluorescence staining with various membrane
dyes or the PtdIns(4,5)P2-binding pleckstrin homology do-
main of phospholipase Cδ [9], but the method also re-
vealed the finer channels and connections, especially in the
upper mesh-like portion of the IPMC (marked as Portion
II in Fig. 6). We have also been able to define the surface
connections where IPMCs open to the exterior of the cell,
including a single channel from one part of an IPMC open-
ing in the deep fold between bleb-like cell surface protru-
sions, or a very complex branching and anastomosing
membrane web merging with the upper surface of a cell.
Overall, we have been able to identify more than
15,000 immature virus buds in this IPMC, associated with
all parts of the structure, although the densities of the
buds varied in different parts of the IPMC. Since the very
basal portion of the IPMC is missing from our model, this
cell would have even more intracellular virus particles.
We also analysed viruses at the cell surface and found that
they were highly concentrated above the areas where the
IPMC opens to the cell surface. Many particles were seen
in groups and clusters, sometimes attached to remaining
membrane extensions. This was true for the channel con-
nection (Arrowheads in Fig. 6 – note the two small groups
of viruses above the channel opening, but as the channel
opening is hidden deep between large membrane blebs,
only the upper cluster of virus buds is visible from the cell
surface) as well as for the larger accumulations of surface
virus buds over the centre of the cell above the larger part
of the IPMC. Normally, these viruses would be released
into the medium and not be observed, but here the use of
budding-arrested mutants has allowed us to define in
detail the sites where viruses are able to exit the IPMCs.
Although we have only been able to analyse one cell at
this resolution, the structure of the IPMC in this cell re-
flects arrangements of IPMC structures and viral bud-
ding sites seen for the MDM profiles analysed for the
cryosections (Figs. 4, 5 and Additional file 5: Table S1),
where we were able to examine multiple cells from sev-
eral donors. Here, we observed cell profiles with deep
IPMCs removed from the cell surface (e.g. Fig. 4e, f ) or
others close to and connecting to the cell surface (e.g.
Fig. 5e–g) and cell profiles with channel-like connections
to the cell surface (not shown). Notably, we even de-
tected two cell profiles that lacked IPMCs (in the sec-
tioned area), but with immature arrested HIV buds
among cell surface membrane sheets and microvilli
(Additional file 5: Table S1: D429 cell profiles 18 and 26,
with virus only at the cell surface) revealing the sensitiv-
ity of the correlative EM analysis and demonstrating that
we were not biased towards cell profiles with viruses in
IPMCs for this analysis. In addition, the cryosection
dataset included a number of cells with prominent cell
surface blebs. Together with other published informa-
tion, the cell shown in Fig. 6 appears to be representative
of a typical HIV-infected macrophage in culture.
Macrophages play key roles in HIV infection. Tissue
macrophages are found in all parts of the body, and are
able to transfer viruses to T cells via virological synapses.
As infected macrophages are relatively long-lived, they
are able to store and archive infectious virus particles,
and they may be particularly important in disseminating
viruses late in HIV infection in the brain. The present
study reveals the detailed structure of the IPMC and
demonstrates that HIV is specifically targeted to this
compartment. Understanding the structure of the
IPMCs may also shed light on the role of HIV-infected
macrophages as a virus reservoir – the assembled virus
particles appear sequestered within the IPMC
(See figure on previous page.)
Fig. 6 Imaging the intracellular plasma membrane-connected compartment (IPMC) by serial block-face scanning electron microscopy (EM) and
3D reconstruction. Monocyte-derived macrophages (MDMs) were infected with HIV-1 R3A PTAP−YP− as in Fig. 5, stained with CellMask orange to
visualise the plasma membrane and IPMCs, fixed and processed for serial block-face scanning EM. a, b Fluorescence and phase contrast images
of a selected cell with prominent intracellular staining. The circle in a marks the position of the nucleus (based on the phase image) and I and II
identify two portions of the IPMC. c–e Serial block-face EM images from this cell. c shows the first of a set of 300 sections. N, nucleus. d, e Higher
magnification details of the two marked areas in (c) corresponding to portions I and II of the IPMC, respectively, reveal the presence of virus buds.
Membrane boundaries of the compartment were segmented (green). The arrows mark the connection between the two portions of the IPMC. f
3D reconstruction of the IPMC shown with xy and xz ortho-slices to indicate the context of the cell volume. The portions of the IPMC are labelled
I and II. Arrowheads mark a short channel connecting portion I to the cell surface, the double-headed arrows show branches associated with
region II, and P indicates a pocket from region II. g Detail of area I with xy and yz ortho-slices. Internal virus buds are shown in magenta. h View
of IPMC portion II showing the mesh-like interconnected IPMC membranes. i–n Analysis of virus buds at the cell surface. i Detail from section
220. The boxed area is enlarged in (j), with the IPMC and cell surface segmented in green and yellow, respectively. Arrows mark clusters of virus
buds at the cell surface between membrane protrusions. k Side view of the IPMC (xz) with virus buds in the IPMC in magenta and at the cell
surface in cyan. l–n Views looking down onto the cell surface (xy orientation) showing cell surface virus buds only (l), cell surface virus buds with
the IPMC (m), or cell surface virus buds and the cell surface in yellow (n). For all reconstructions, the IPMC is shown in green, cell surface yellow,
IPMC virus buds magenta, cell surface virus buds cyan and the nucleus in blue. White arrowheads mark the channel from IPMC portion I towards
the cell surface (in f, g and k) or the cell surface virus buds above the channel opening in l–n. Scale bars b, 20 μm, c, i and n, 5 μm and d, e and
j, 1 μm. See also Additional file 6: Figure S6, Additional file 7: Movie S1, Additional file 8: Figure S7 and Additional file 9: Movie S2
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environment, largely protected from the immune re-
sponse [42], but able to infect CD4+ T cells following
regulated release of HIV via virological synapses [17, 18].
In this way, macrophages and their specialised IPMCs
directly contribute to HIV pathogenesis.
Conclusion
To investigate the fidelity of HIV-1 targeting to IPMCs
in human MDMs, we used mutants unable to complete
the ESCRT-dependent scission reaction to arrest viruses
at their budding sites, allowing us to capture all HIV as-
sembly events. Detailed morphological analysis of the
distribution of the budding-arrested viruses by immuno-
fluorescence staining and confocal microscopy, as well
as by EM, showed fewer than 5 % of the HIV buds at
the cell surface, thereby demonstrating specific targeting
of HIV assembly to IPMCs. High resolution reconstruc-
tion and segmentation of an infected macrophage by ser-
ial block-face scanning EM revealed the detailed
ultrastructure of an IPMC within a large cell volume,
and allowed us to observe the location of individual bud-
ding events. These studies demonstrate that HIV assem-
bly is specifically targeted to complex IPMCs and
indicates HIV particles stored in these protected sites
may function as virus reservoirs.
Methods
Reagents and antibodies
Unless indicated otherwise, tissue culture media and
supplements were obtained from Life Technologies
(Paisley, UK), tissue culture plastic from Thermo Fisher
Scientific (Cramlington, UK) or Techno Plastic Products
AG (Trasadingen, Switzerland) and chemicals were ob-
tained from Sigma-Aldrich (Dorset, UK). Restriction en-
zymes and the DNA ladder were purchased from
Promega (Southampton, UK) and EM chemicals and
supplies from Agar Scientific (Stansted, UK) or TAAB
Laboratories (Reading, UK).
Antibodies against HIV-1 p24/p55 (38:96 K and EF7,
ARP365 and ARP366, respectively), p17 (4C9, ARP342)
or Env (2G12, ARP3064) were obtained from the Na-
tional Institute for Biological Standards and Control,
Center for AIDS Reagents (NIBSC CFAR, South
Mimms, UK; http://www.nibsc.org/science_and_re-
search/virology/centre_for_aids_reagents.aspx). The
mouse monoclonal antibody Kal-1 against HIV-1 p24
was from Dako (Thetford, UK; Dako Cat# M0857, RRI-
D:AB_2335686). The rabbit polyclonal anti-ALIX anti-
body was a gift from Wes Sundquist (University of Utah,
Salt Lake City, USA). Anti-CD44 (MEM-85; Abcam
Cat# ab2212 RRID:AB_302891) and anti-VDAC-1
(ab15895; Abcam Cat# ab15895 RRID:AB_2214787)
were from Abcam Ltd. (Cambridge, UK), anti-Tsg101
(M-19) from Santa Cruz Biotechnology (Cat# sc-6037
RRID:AB_2208099), and mouse anti-adaptin-γ (clone 88;
BD Bioscience Cat# 610386 RRID:AB_397769) from BD
Bioscience. Horseradish peroxidase-conjugated goat
anti-mouse and anti-rabbit were purchased from Life
Technologies (Thermo Fisher Scientific #32430 RRI-
D:AB_1185566; #31460 RRID:AB_228341, respectively),
horseradish peroxidase-conjugated donkey anti-goat
from Santa Cruz (Santa Cruz #sc-2020 RRID:AB_
631728) and the Alexa Fluor-labelled secondary antibody
reagents were from Life Technologies (Thermo Fisher
Scientific #A21121 RRID:AB_2535764; #A21134 RRI-
D:AB_10393343; #A21242 RRID:AB_2535811; #A21135
RRID:AB_2535774; #A11037 RRID:AB_2534095 and
A11059 RRID:AB_2534106).
Cell lines and macrophage preparation
HEK 293 T and TZM-bl cells were maintained in Dul-
becco’s Modified Eagle’s Medium (DMEM) supple-
mented with 10 % v/v fetal bovine serum (FBS),
2 mM L-glutamine, 100 units/mL penicillin and 100 μg/
mL streptomycin. MDMs were prepared from peripheral
blood mononuclear cells isolated from buffy coats ob-
tained from healthy blood donors (National Blood
Services, Essex, UK) as described previously [7, 18].
Monocytes were differentiated with macrophage-colony
stimulating factor (M-CSF, 10 ng/mL; R&D Systems,
Abington, UK) and cultured in Roswell Park Memorial
Institute (RPMI) 1640 medium supplemented with 10 %
human serum, 100 units/mL penicillin and 100 μg/mL
streptomycin.
Plasmids and viruses
The HIV-1 construct pNL4.3-R3A, a chimeric virus con-
taining the env gene of the HIV-1 R3A strain [43] in the
NL4.3 backbone, was a gift from J. Hoxie (University of
Pennsylvania, Philadelphia, USA). A Gag fragment con-
taining the entire p6 domain was excised from pNL4.3-
R3A with EcoRI and ApaI and subcloned into pEGFP-Nl
(Addgene). Using the QuickChange® Site-Directed Muta-
genesis Kit (Agilent Technologies, Wokingham, UK), the
new plasmid carrying the EcoRI/ApaI fragment from
pNL4.3-R3A (hereafter, called “carrier plasmid”) was
mutagenised at the PTAP and YP residues, or a stop
codon was introduced at the beginning of p6 using the
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reverse, TCTGGTCTGCTCTGTTAAAAATTCCCTG
GCCTTCCCTTGTGGG. The mutagenised carrier
fragments were excised from the carrier plasmid and re-
inserted into pNL4.3-R3A, generating the mutant provi-
ruses YP−, PTAP−, PTAP−YP− and Δp6. pCMVGag WT
was generated from Gag-GFP in pEGFP-N1 (Herminda-
Matsumoto and Resh 2000, provided by W. Sundquist)
by deleting the GFP sequence. Stocks of infectious HIV-
1 R3A PTAP− or PTAP−YP− were prepared by transfect-
ing HEK 293 T cells with a mixture of pNL4.3-R3A
PTAP− or PTAP−YP− and pCMVGag WT. After 24 h,
media were collected, the rescued viruses were purified
by ultracentrifugation through a 20 % w/v sucrose cush-
ion and stored frozen in RPMI 1640. Virus titres were
measured on TZM-bl indicator cells, using the Galacto-
Star Reporter Gene Assay System (Life Technologies) as
previously described [7, 18].
Infections and transfections
HEK 293 T cells were transfected with FuGENE HD
(Roche, Welwyn Garden City, UK). Fourteen-day-old
MDMs were transfected by electroporation using the
Amaxa Human Macrophage Nucleofector Kit and
Amaxa Nucleofector II (Lonza, Kent, UK), and incu-
bated as described [9]. MDMs were infected with HIV-1
WT or the mutant viruses at 3 and 6 focus forming units
per cell (FFU/cell), respectively, by spinoculation (centri-
fugation at 1300 g and 25 °C for 2 h) and cultured for
7 days as described [7].
Analysis of HIV release
For released viruses, culture supernatants were cleared
by centrifugation, overlaid onto 20 % sucrose in PBS and
centrifuged at 100,000 g for 2 h at 4 °C. Cells were
washed in PBS and cells or the purified virus pellets
were lysed in Laemmli reducing sample buffer (Sigma-
Aldrich, Dorset, UK), heated for 10 min at 95 °C and re-
solved, blotted and analysed with appropriate antibodies
as described before [7, 9, 18]. Signal intensities on west-
ern blots were quantified using ImageJ. Virus release ef-
ficiencies were calculated as the amount of p24 + p55 in
the virus blot relative to the total p24 and p55 in cell
and virus lysates.
Confocal microscopy
MDMs on coverslips were fixed in 4 % formaldehyde,
washed, quenched in 50 mM NH4Cl in PBS and perme-
abilized with 0.1 % Triton X-100 in blocking buffer
(6 mg/mL purified human IgG and 0.5 % BSA in PBS).
Cells were incubated in primary and secondary anti-
bodies as described previously [7, 9]. Nuclei were
counter-stained with 0.5 μg/mL Hoechst 33258 (Life
Technologies), and the coverslips were mounted with
Mowiol (Merck Millipore, Darmstadt, Germany).
Confocal images were acquired with a Leica TCS SP3
confocal microscope, 63× oil objective and Leica LAS
AF Software (Leica Microsystems, Milton Keynes, UK).
Images were processed using ImageJ and assembled
using Adobe Illustrator CS4.
Preparation of cells for cryosectioning and EM
immunolabelling
Cells were prepared for cryosectioning as previously de-
scribed [4, 7]. Briefly, cells were fixed in 4 % formalde-
hyde in 0.1 M sodium phosphate buffer, pH 7.4,
embedded in 12 % gelatine, infiltrated with 2.3 M su-
crose and frozen in liquid nitrogen. Samples were
screened by immunofluorescence staining of semi-thin
cryosections (0.5 μm) as described [7] and imaged with
an Axioskop microscope (Carl Zeiss, Hertfordshire, UK)
fitted with a charge-coupled device camera (Orca-ER;
Hamamatsu), controlled by OPENLAB 5.0.2 software
(Improvision, Perkin Elmer). Images were processed
using Adobe Photoshop CS4.
EM immunolabelling was as described [4, 44, 45].
Briefly, ultrathin cryosections (~50 nm) on formvar/car-
bon-coated EM grids or H6 finder grids were quenched in
50 mM glycine/50 mM NH4Cl, washed and stained with
mouse antibodies to p24/p55 prepared in 2 % BSA, 0.2 %
acetylated BSC (BSA-c, Aurion, Wageningen, The
Netherlands) in PBS, rabbit anti-mouse Alexa-488 and
Protein A-gold (PAG, The EM Lab, Utrecht University,
The Netherlands). Some grids were double labelled with
antibodies to HIV Env, fixed in 1 % glutaraldehyde,
washed, quenched and then stained for p24/p55, as above
[7]. For correlative on-grid light and EM, sections were in-
cubated with Hoechst 33258 to stain the nuclei, mounted
in 50 % glycerol in H2O and fluorescent cells were imaged
with an Axioskop microscope (Zeiss) as above. All sec-
tions were stained with 2 % neutral uranyl acetate and em-
bedded in 0.4 % uranyl acetate in 2 % methylcellulose [45].
Specimens were examined with a Tecnai 20 (FEI,
Eindhoven, The Netherlands) using a Morada camera and
iTEM software (Olympus Soft Imaging Solutions), and
processed with Adobe Photoshop CS4.
Conventional EM of Epon-embedded cells
HEK 293 T cells were fixed for 30 min in 1.5 % glutaral-
dehyde, 4 % formaldehyde in 0.1 M sodium cacodylate
buffer, pH 7.4, post-fixed in reduced osmium (1.5 % po-
tassium ferricyanide, 1 % osmium tetroxide) at 4 °C for
1 h, and treated with 1 % tannic acid in 0.05 M sodium
cacodylate for 45 min in the dark. The cells were washed
with 1 % sodium sulphate in 0.05 M sodium cacodylate,
and dehydrated and embedded in Epon 812 resin. Ultra-
thin sections were stained with lead citrate and imaged
with a Tecnai 20 EM as above.
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Serial block-face scanning EM
Seven-day-old MDMs were infected with HIV-1 R3A PTAP
−YP− for 7 days and incubated in 5 μg/mL CellMask orange
plasma membrane stain (Invitrogen Molecular Probes, Paisley,
UK) for 10 min at 37 °C. Cells were fixed in 4 % formaldehyde,
washed and imaged on an inverted light microscope (DMIL
LED; Leica, Vienna, Austria) to identify cells with IPMCs, and
bright-field and fluorescence images of the cells of interest
were acquired at low magnification. To mark the selected cells,
a ring of adjacent cells was removed by scratching manually
with forceps. This allowed the region of the coverslip (and
later, the resin block) containing the cell of interest to be easily
visible to the naked eye, once the cells were osmicated. Cells
were then further fixed with 2 % formaldehyde, 1.5 % glutaral-
dehyde and incubated with reduced osmium at 4 °C. The cells
were treated with 1 % thiocarbohydrazide, before a 30 min in-
cubation in 2 % osmium tetroxide and an overnight treatment
with 1 % uranyl acetate. A final en bloc stain was performed
with lead aspartate before the sample was dehydrated in etha-
nol and embedded in Durcupan resin.
Embedded EM blocks were examined to identify the
cells of interest, trimmed, and ultrathin sections of the
cells of interest were taken and examined by transmis-
sion EM to confirm virus infection. The region of inter-
est was then excised and mounted with conductive silver
epoxy resin onto specimen pins. Samples were further
trimmed before being coated with gold palladium and
mounted in the 3View microtome (Gatan, CA, USA)
coupled to a Sigma VP scanning electron microscope
(SEM; Zeiss, Cambridge, UK). Once aligned, the sample
and microtome were returned to the SEM chamber and
pumped to a vacuum pressure of 5 Pa. The region of
interest on the block face was re-located in the SEM
using backscattered electron detection and the imaging
and cutting parameters were optimised. The voltage was
set at 2 kV using the high current setting and a 20 μ
aperture, and imaging parameters were set at 8 k ×
8 k pixels, with a horizontal field width of 32.8 μm and a
pixel size of 4 nm, with a slice thickness of 50 nm. For
segmentation, datasets were imported into Amira (FEI
VSG, France), and cells of interest were manually seg-
mented, reconstructed and rendered in 3D. The loca-
tions of virus buds were manually marked on the
sections using the TrakEM2 module of ImageJ, coordi-
nates of the virus particles were calculated using a cus-
tom python script [46] and loaded into Amira for
visualization.
Additional files
Additional file 1: Figure S1. siRNA-mediated depletion of Tsg101 and/or
ALIX has a minimal effect on virus release in monocyte-derived macro-
phages (MDMs). (A) Diagram showing the experimental set-up for siRNA
knockdown in MDMs. Seven- or 8-day-old MDMs were infected with HIV-1
BaL (3 FFU/cell), on day 0. One day later, duplicate culture wells per donor
were transfected with the appropriate siRNAs (Stealth siRNAs for ALIX,
HSS115204; Tsg101, HSS111013; or negative control, 12935-300) using
LipofectamineTM RNAiMAX (Life Technologies) and cultured for 6 days.
Media containing virus released during a 24-h window from 6–7 days after
infection were collected and concentrated by ultracentrifugation through
sucrose cushions. The virus pellets and cells were lysed and analysed by
western blotting. Blots for VDAC-1 and adaptin-γ were included as loading
controls. (B, C) Single knockdown of either ALIX or Tsg101 (B), or double
knockdown of both proteins (C). For analysis, unsaturated band signal
intensities were quantified using ImageJ. Knockdown of ALIX or Tsg101 are
shown by comparison to the control siRNA. Virus release efficiencies were
calculated as the amount of viral p24 + p55 + the p24 in the cell lysates
(in macrophages HIV accumulates in IPMCs, and therefore cell lysate p24
represents mature virus that is budded from the host plasma membrane)
divided by the total p24 and p55 in cell and virus lysates. Although ALIX
and Tsg101 were efficiently depleted, this had minimal effects on HIV
release. Data represent independent experiments with MDMs from four and
three blood donors in (B) and (C), respectively. (TIF 1900 kb)
Additional file 2: Figure S2. Generation of release-defective HIV-1 R3A
proviruses and preparation of infectious virus stocks. (A) Schematic
representation of the HIV-1 NL4.3-R3A Gag polyprotein. The amino acid
sequence of the p6 subdomain in the WT is shown with the Tsg101 and
ALIX binding motifs, PTAP and YPLSTSL, respectively, highlighted in green.
For the mutants, sequence changes are marked in red, and dashes denote
amino acids identical to the WT. The red asterisk indicates the location of
the stop codon in Δp6. (B) Determination of the optimal conditions for
rescuing release-defective viruses. HEK 293 T cells were transfected with
pNL4.3-R3A WT, PTAP− alone, or PTAP− together with increasing concentra-
tions of pCMVGag that expresses WT p55Gag. Cells were incubated for 24 h,
and cell lysates and released viruses analysed by western blotting. (C)
Quantitative analysis of virion-associated p24 in the medium of cells
producing HIV-1 R3A PTAP− virus rescued by co-expression of WT p55Gag.
(D) Virus stocks were prepared from HIV-1 R3A WT, or from the PTAP−
mutant using a 12:1 ratio of pNL4.3-R3A PTAP−: pCMVGag WT, and
infectious titres determined on TZM-bl cells. For (C) and (D), error bars
represent SD for two independent experiments. (TIF 910 kb)
Additional file 3: Figure S3. Distribution of HIV-1 R3A WT or PTAP–YP–
in infected monocyte-derived macrophages (MDMs). Seven-day-old
MDMs were infected with HIV-1 R3A WT or the rescued release-defective
PTAP−YP− for 7 days, fixed, immunolabelled with anti-p24/55 antibodies
(Kal-1, green), p17 (4C9, red) and CD44 (magenta) and examined by
confocal microscopy. Selected sections from the confocal series for the
cells shown in Fig. 3. Numbers indicate the optical slice in the confocal
series. (A) HIV-1 R3A WT, the cell shown in Fig. 3a. (B–D) HIV-1 R3A PTAP
−YP−, showing the cells in Fig. 3b, c and e, respectively. Note that the cell
in (D) lacks a CD44+ intracellular plasma membrane-connected
compartment. Scale bars, 20 μm. (TIF 9159 kb)
Additional file 4: Figure S4. Distribution of HIV-1 R3A PTAP–YP– in
monocyte-derived macrophages (MDMs) and quantitation of Gag
fluorescence. (A) Selected sections from the confocal series for the
infected MDM shown in Fig. 3d, HIV-1 R3A PTAP−YP− stained p24/55
(Kal-1, green), p17 (4C9, red) and CD44 (magenta). Numbers indicate the
slice in the confocal series (numbering from the bottom to the top of
the cell). Yellow arrows indicate some of the rare virus puncta at the cell
surface. Scale bar, 20 μm. (B–C) Quantitation of fluorescence intensities per
cell for MDMs infected with HIV-1 R3A WT or the rescued release-defective
PTAP−YP− for 7 days for cells from two blood donors as indicated. Total
staining with Kal-1 anti-p24/55 (B) or 4C9 anti-p17 (C) was analysed on 3D
images using ImageJ. In (C) the symbols below the x-axis represent cells for
which no p17 fluorescence was recorded. (TIF 7562 kb)
Additional file 5: Table S1. Quantitation of virus buds and membrane
lengths for cryosections of monocyte-derived macrophages (MDMs)
infected with budding-arrested HIV mutants. MDMs from four different
donors were infected with the HIV-1 R3A mutants PTAP− or PTAP−YP−,
and infected MDMs located by on-grid immunolabelling. Electron
microscopy images were recorded and analysed by counting the number
of virus buds seen either at the cell surface or within intracellular plasma
membrane-connected compartments (IPMCs). Lengths of surface or IPMC
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membrane within the sections were measured by tracing (see Methods).
Data from all of the cells summarised in Table 1. (XLSX 46 kb)
Additional file 6: Figure S5. Imaging a monocyte-derived macrophage
(MDM) infected with HIV-1 R3A PTAP−YP− by serial block-face scanning
electron microscopy (SEM). Selected sections from the serial block face
SEM data set. Section numbers from the first section near the bottom of
the cell (000) are indicated in the top right of the panels. Images have
been segmented for the intracellular plasma membrane-connected
compartment (IPMC; green) or cell surface plasma membrane (yellow). I
and II show the two portions of the IPMC and the white circle indicates a
narrow channel connecting IPMC portion I to the cell surface (white
arrow in section 108). Towards the top of the cell, clusters of virus buds
are seen between membrane protrusions at the cell surface (e.g. black
arrows in section 200 and 240). Scale bar, 5 μm. (TIF 8739 kb)
Additional file 7: Movie S1. Imaging a monocyte-derived macrophage
infected with HIV-1 R3A PTAP−YP− by serial block-face scanning electron
microscopy (SEM). Movie showing all 300 sections from the serial block-face
SEM data set, from the bottom of the cell towards the top. Note the
complex intracellular plasma membrane-connected compartment structure
filled with virus particles, and some cell surface virus buds near the top of
the cell. (MOV 16087 kb)
Additional file 8: Figure S6. Un-cropped images and additional views
from the cell shown in Fig. 6. (A, B) Slices 000 and 220 in xy orientation,
with the intracellular plasma membrane-connected compartment (IPMC)
segmented in green and the cell surface plasma membrane in yellow.
(C–E) xz side view as in Fig. 6k. The positions of section 000 and section
220 are indicated by dashed lines. (D) and (E) show the same view as in
(C) with the cell surface (yellow) transparent (D) or opaque (E). (F, G)
Uncropped xy view as in Fig. 6l–n, with cell surface virus particles only
(cyan, F) or with the cell surface (transparent yellow, G). (H–J) yz side
views, representation as in (C–E). Note the clustering of cell surface virus
particles (cyan) above IPMC exit sites. (TIF 15003 kb)
Additional file 9: Movie S2. Model of the cell shown in Fig. 6. The
movie shows four rotations of the model with (1) the intracellular plasma
membrane-connected compartment (IPMC) only (green). Note branches
connecting different parts of the IPMC. (2) Transparent IPMC, revealing
internal virus buds (magenta) and (3) cell surface virus buds (cyan).
Rotation (4) also shows the cell surface (yellow). Note the clustering of
cell surface virus particles (cyan) above IPMC exit sites. (MOV 13075 kb)
Abbreviations
EM, electron microscopy; ESCRT, endosomal sorting complexes required for
transport; IPMC, intracellular plasma membrane-connected compartment;
MDM, monocyte-derived macrophage; PtdIns(4,5)P2, phosphatidylinositol-4,5-
bisphosphate
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